QA: Dynavax Technologies CORP in us_pharma/2013

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001029142_2014_Dynavax_Technologies_CORP.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001029142, Dynavax Technologies CORP

  xvar xval
0 AssetsCurrent 192,378,000
1 IntangibleAssetsNetIncludingGoodwill 2,579,000
2 PropertyPlantAndEquipmentNet 8,706,000
3 remainder_Assets 959,000
4 LiabilitiesCurrent 16,192,000
5 LiabilitiesNoncurrent 963,000
6 remainder_Liabilities 1,173,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 25,943,000
9 ResearchAndDevelopmentExpense 50,870,000
10 remainder_Expenses 926,000
11 remainder_Revenues 11,251,000
12 remainder_NetIncome -232,000
13 remainder_ComprehensiveNetIncome 447,000
  yvar yval
0 Assets 204,622,000
1 Liabilities 18,328,000
2 Expenses 77,739,000
3 Revenues 11,251,000
4 StockholdersEquity 186,294,000
5 NetIncome -66,720,000
6 ComprehensiveNetIncome -66,496,500
7 BaseVar 156,309,500
8 EconomicCapitalRatiobeforeLimitedLiability 3.05
9 EconomicCapitalRatio 3.72

Edgar->Model Mapping

Feature Distribution

Change over Time